HydrALAZINE HYDROCHLORIDE INJECTION recalled over temperature-control failures
- Recall date
- March 8, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Mckesson Medical Surgical recalls hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, AP…
- Recall number
- D-0668-2017
- FDA classification
- Class II
- Brand / firm
- Mckesson Medical Surgical
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.
Get recall alerts
Free email alert whenever Mckesson Medical Surgical has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mckesson Medical Surgical